Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Sylvia Chen, Natalia Sutiman, Clara Zhenxian Zhang, Yingnan Yu, Shirley Lam, Chiea Chuen Khor & Balram Chowbay. (2016) Pharmacogenetics of irinotecan, doxorubicin and docetaxel transporters in Asian and Caucasian cancer patients: a comparative review. Drug Metabolism Reviews 48:4, pages 502-540.
Read now
Read now
Svetlana Bureeva & Yuri Nikolsky. (2011) Quantitative knowledge-based analysis in compound safety assessment. Expert Opinion on Drug Metabolism & Toxicology 7:3, pages 287-298.
Read now
Read now
Articles from other publishers (18)
Petra Bendova, Barbara Pardini, Simona Susova, Jachym Rosendorf, Miloslav Levy, Pavel Skrobanek, Tomas Buchler, Jan Kral, Vaclav Liska, Ludmila Vodickova, Stefano Landi, Pavel Soucek, Alessio Naccarati, Pavel Vodicka & Veronika Vymetalkova. (2021) Genetic variations in microRNA-binding sites of solute carrier transporter genes as predictors of clinical outcome in colorectal cancer. Carcinogenesis 42:3, pages 378-394.
Crossref
Crossref
Sara García Gil, Ruth Ramos Díaz, Gloria Julia Nazco Casariego, Marta Llanos Muñoz, Maria Micaela Viña Romero, Braulio Martín Calero, Jose Antonio Pérez Pérez & Fernando Gutiérrez Nicolás. (2018) Efecto de los polimorfismos en UGT, SLCO, ABCB y ABCC en la toxicidad del tratamiento con irinotecán. Medicina Clínica 151:11, pages 425-430.
Crossref
Crossref
Sara García Gil, Ruth Ramos Díaz, Gloria Julia Nazco Casariego, Marta Llanos Muñoz, Maria Micaela Viña Romero, Braulio Martín Calero, Jose Antonio Pérez Pérez & Fernando Gutiérrez Nicolás. (2018) Effect of UGT, SLCO, ABCB and ABCC polymorphisms on irinotecan toxicity. Medicina Clínica (English Edition) 151:11, pages 425-430.
Crossref
Crossref
Milica Vučetić, Yann Cormerais, Scott K. Parks & Jacques Pouysségur. (2017) The Central Role of Amino Acids in Cancer Redox Homeostasis: Vulnerability Points of the Cancer Redox Code. Frontiers in Oncology 7.
Crossref
Crossref
Marina Bessarabova, Tatiana Nikolskaya & Yuri Nikolsky. 2014. Handbook of Personalized Medicine. Handbook of Personalized Medicine
257
289
.
Elena De Mattia, Giuseppe Toffoli, Jerry Polesel, Mario D’Andrea, Giuseppe Corona, Vittorina Zagonel, Angela Buonadonna, Eva Dreussi & Erika Cecchin. (2013) Pharmacogenetics of ABC and SLC transporters in metastatic colorectal cancer patients receiving first-line FOLFIRI treatment. Pharmacogenetics and Genomics 23:10, pages 549-557.
Crossref
Crossref
Fabio Arnesano, Maurizio Losacco & Giovanni Natile. (2013) An Updated View of Cisplatin Transport. European Journal of Inorganic Chemistry 2013:15, pages 2701-2711.
Crossref
Crossref
Jan LewerenzSandra J. HewettYing HuangMaria LambrosPeter W. GoutPeter W. KalivasAnn MassieIlse SmoldersAxel MethnerMathias PergandeSylvia B. SmithVadivel GanapathyPamela Maher. (2013)
The Cystine/Glutamate Antiporter System x
c
−
in Health and Disease: From Molecular Mechanisms to Novel Therapeutic Opportunities
. Antioxidants & Redox Signaling 18:5, pages 522-555.
Crossref
Crossref
Andrée-Anne Boivin, Héloïse Cardinal, Azemi Barama, Judith Naud, Vincent Pichette, Marie-Josée Hébert & Michel Roger. (2013) Influence of SLCO1B3 Genetic Variations on Tacrolimus Pharmacokinetics in Renal Transplant Recipients. Drug Metabolism and Pharmacokinetics 28:3, pages 274-277.
Crossref
Crossref
Eun Sil Oh, Choon Ok Kim, Sung Kweon Cho, Min Soo Park & Jae-Yong Chung. (2013) Impact of ABCC2, ABCG2 and SLCO1B1 Polymorphisms on the Pharmacokinetics of Pitavastatin in Humans. Drug Metabolism and Pharmacokinetics 28:3, pages 196-202.
Crossref
Crossref
Sudeep P. Pushpakom & Munir Pirmohamed. 2011. Stephens' Detection and Evaluation of Adverse Drug Reactions. Stephens' Detection and Evaluation of Adverse Drug Reactions
121
156
.
Yuri Nikolsky, Marina Bessarabova, Eugene Kirillov, Zoltan Dezso, Weiwei Shi & Tatiana Nikolskaya. 2011. Applied Statistics for Network Biology. Applied Statistics for Network Biology
415
442
.
Herman Burger, Walter J. Loos, Karel Eechoute, Jaap Verweij, Ron H.J. Mathijssen & Erik A.C. Wiemer. (2011) Drug transporters of platinum-based anticancer agents and their clinical significance. Drug Resistance Updates 14:1, pages 22-34.
Crossref
Crossref
W Shi, M Bessarabova, D Dosymbekov, Z Dezso, T Nikolskaya, M Dudoladova, T Serebryiskaya, A Bugrim, A Guryanov, R J Brennan, R Shah, J Dopazo, M Chen, Y Deng, T Shi, G Jurman, C Furlanello, R S Thomas, J C Corton, W Tong, L Shi & Y Nikolsky. (2010) Functional analysis of multiple genomic signatures demonstrates that classification algorithms choose phenotype-related genes. The Pharmacogenomics Journal 10:4, pages 310-323.
Crossref
Crossref
A.-N. Pham, P. E. Blower, O. Alvarado, R. Ravula, P. W. Gout & Y. Huang. (2009) Pharmacogenomic Approach Reveals a Role for the xFormula Cystine/Glutamate Antiporter in Growth and Celastrol Resistance of Glioma Cell Lines. Journal of Pharmacology and Experimental Therapeutics 332:3, pages 949-958.
Crossref
Crossref
Andrée-Anne Boivin, Héloïse Cardinal, Azemi Barama, Vincent Pichette, Marie-Josée Hébert & Michel Roger. (2010) Organic Anion Transporting Polypeptide 1B1 (OATP1B1) and OATP1B3: Genetic Variability and Haplotype Analysis in White Canadians. Drug Metabolism and Pharmacokinetics 25:5, pages 508-515.
Crossref
Crossref
Xin Gao, Lina Lin & Ying Huang. (2009) Application of model selection technique in chemogenomic data analysis. Statistical Analysis and Data Mining 2:3, pages 186-191.
Crossref
Crossref
Anh-Nhan Pham, Jeffrey Wang, Jialong Fang, Xin Gao, Yilong Zhang, Paul E. Blower, Wolfgang Sadée & Ying Huang. (2008) Pharmacogenomics Approach Reveals MRP1 (ABCC1)-Mediated Resistance to Geldanamycins. Pharmaceutical Research 26:4, pages 936-945.
Crossref
Crossref